Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pink Sheet Team

Editorial Team

International

The policy and regulatory insights advantage for biopharma decision-makers around the globe.

Latest From Pink Sheet Team

Pink Sheet Podcast: House User Fee Bill, Push For OTC Naloxone, SCOTUS Overturning Roe v. Wade

Pink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.

Legislation Legal Issues

Pink Sheet Podcast: COVID-19 Vaccine Boosters, Clinical Trial Diversity, FDA Returns To The Office

Pink Sheet reporter and editors discuss CDC advisors’ views on COVID-19 vaccine booster policy, new FDA guidance to promote clinical trial diversity, and what some FDA employees are finding when they return to the White Oak headquarters.

Coronavirus COVID-19 Clinical Trials

Pink Sheet Podcast: Amylyx Adcom Take-Aways, FDA Budget Request, Aduhelm Coverage Advocacy

Pink Sheet

Advisory Committees Legislation

Pink Sheet Podcast: Lower US FDA EUA Approval Standard, New Vaccines’ Role, HHS Biosimilar Study

Pink Sheet reporters and editors discuss changes to the standard for some COVID-19 treatment emergency use authorizations, late-coming COVID-19 vaccines and their potential effect on the market, and an upcoming HHS biosimilar use and cost study.

Coronavirus COVID-19 Vaccines

Pink Sheet Podcast: Califf Confirmed, Lessons From Sintilimab Adcom, Generic Industry Execs Meet

Pink Sheet reporters and editors consider Robert Califf’s priorities now that he is FDA commissioner, what sponsors can learn from the sintilimab advisory committee meeting, and the latest generics news from a major (and in-person) trade association conference.

Leadership Cancer

Pink Sheet Podcast: Authorizing Pfizer’s Vaccine In Young Children, States v FDA, Zohydro’s Exit

Pink Sheet reporters and editors discuss the EUA request for Pfizer’s COVID-19 vaccine in children younger than 5, the full approval of Moderna’s COVID-19 vaccine, states ignoring FDA treatment and vaccine recommendations, and Zohydro ER’s withdrawal in the US.

Coronavirus COVID-19 Drug Review
See All
UsernamePublicRestriction

Register